Suyash Prasad, M.B.B.S, F.F.P.M
2020
In 2020, Suyash Prasad, M.B.B.S, F.F.P.M earned a total compensation of $4M as Chief Medical Officer and Head of Research and Development at Taysha Gene Therapies.
Compensation breakdown
| Non-Equity Incentive Plan | $129,975 |
|---|---|
| Salary | $216,833 |
| Stock Awards | $3,668,409 |
| Other | $152 |
| Total | $4,015,369 |
FFPM received $3.7M in stock awards, accounting for 91% of the total pay in 2020.
FFPM also received $130K in non-equity incentive plan, $216.8K in salary and $152 in other compensation.
Rankings
In 2020, Suyash Prasad, M.B.B.S, F.F.P.M's compensation ranked 2,838th out of 13,090 executives tracked by ExecPay. In other words, FFPM earned more than 78.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,838 out of 13,090 | 78th |
Division Manufacturing | 1,090 out of 5,618 | 81st |
Major group Chemicals And Allied Products | 402 out of 2,251 | 82nd |
Industry group Drugs | 346 out of 1,951 | 82nd |
Industry Biological Products, Except Diagnostic Substances | 92 out of 411 | 78th |
Source: SEC filing on April 28, 2022.
FFPM's colleagues
We found two more compensation records of executives who worked with Suyash Prasad, M.B.B.S, F.F.P.M at Taysha Gene Therapies in 2020.